References
1. Barrera M, Atenafu E. Cognitive, educational, psychosocial adjustment
and quality of life of children who survive hematopoietic SCT and their
siblings. Bone Marrow Transplantation. 2008;42(1):15-21.
2. Di Giuseppe G, Thacker N, Schechter T, Pole JD. Anxiety, depression,
and mental health-related quality of life in survivors of pediatric
allogeneic hematopoietic stem cell transplantation: a systematic review.Bone Marrow Transplantation. 2020;55(7):1240-1254.
3. Janicsák H, Ungvari GS, Gazdag G. Psychosocial aspects of
hematopoietic stem cell transplantation. World J Transplant.2021;11(7):263-276.
4. Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN. Physical,
psychological, and social sequelae following hematopoietic stem cell
transplantation: a review of the literature. Psychooncology.2009;18(2):113-127.
5. Byar KL, Eilers JE, Nuss SL. Quality of life 5 or more years
post-autologous hematopoietic stem cell transplant. Cancer Nurs.2005;28(2):148-157.
6. Le RQ, Bevans M, Savani BN, et al. Favorable Outcomes in Patients
Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell
Transplantation for Hematologic Malignancies. Biology of Blood and
Marrow Transplantation. 2010;16(8):1162-1170.
7. Bevans M. Health-related quality of life following allogeneic
hematopoietic stem cell transplantation. Hematology Am Soc Hematol
Educ Program. 2010;2010:248-254.
8. Elwadhi D, Khandelwal SK, Kumar L, Sharma A. Short-Term Impact of
Hematopoietic Stem Cell Transplantation on Psychiatric Morbidity and
Quality of Life in Hematological Malignancies in Adults. Indian J
Psychol Med. 2020;42(1):61-68.
9. Liang H, Pan L, Xie Y, et al. Health-related quality of life in
pediatric patients with β-thalassemia major after hematopoietic stem
cell transplantation. Bone Marrow Transplantation. 2022.
10. Barrera M, Boyd-Pringle LA, Sumbler K, Saunders F. Quality of life
and behavioral adjustment after pediatric bone marrow transplantation.Bone Marrow Transplant. 2000;26(4):427-435.
11. Phipps S, Brenner M, Heslop H, Krance R, Jayawardene D, Mulhern R.
Psychological effects of bone marrow transplantation on children and
adolescents: preliminary report of a longitudinal study. Bone
marrow transplantation. 1995;15(6):829-835.
12. Phipps S, Dunavant M, Garvie PA, Lensing S, Rai SN. Acute
health-related quality of life in children undergoing stem cell
transplant: I. Descriptive outcomes. Bone Marrow Transplantation.2002;29(5):425-434.
13. Phipps S, Peasant C, Barrera M, Alderfer MA, Huang Q, Vannatta K.
Resilience in children undergoing stem cell transplantation: results of
a complementary intervention trial. Pediatrics.2012;129(3):e762-770.
14. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer
patients, age, race-ethnicity, gender and smoking predict adverse
comorbidity, which in turn predicts treatment and survival.Journal of clinical epidemiology. 2004;57(6):597-609.
15. Kirtane K, Lee SJ. Racial and ethnic disparities in hematologic
malignancies. Blood, The Journal of the American Society of
Hematology. 2017;130(15):1699-1705.
16. Abraham IE, Rauscher GH, Patel AA, et al. Structural racism is a
mediator of disparities in acute myeloid leukemia outcomes. Blood,
The Journal of the American Society of Hematology.2022;139(14):2212-2226.
17. Fiala MA, Wildes TM. Racial disparities in treatment use for
multiple myeloma. Cancer. 2017;123(9):1590-1596.
18. Barker JN, Boughan K, Dahi PB, et al. Racial disparities in access
to HLA-matched unrelated donor transplants: a prospective 1312-patient
analysis. Blood Advances. 2019;3(7):939-944.
19. Baker KS, Davies SM, Majhail NS, et al. Race and socioeconomic
status influence outcomes of unrelated donor hematopoietic cell
transplantation. Biol Blood Marrow Transplant.2009;15(12):1543-1554.
20. Mielcarek M, Gooley T, Martin PJ, et al. Effects of race on survival
after stem cell transplantation. Biol Blood Marrow Transplant.2005;11(3):231-239.
21. Eckrich MJ, Ahn KW, Champlin RE, et al. Effect of race on outcomes
after allogeneic hematopoietic cell transplantation for severe aplastic
anemia. Am J Hematol. 2014;89(2):125-129.
22. Ballen KK, Klein JP, Pedersen TL, et al. Relationship of
race/ethnicity and survival after single umbilical cord blood
transplantation for adults and children with leukemia and
myelodysplastic syndromes. Biol Blood Marrow Transplant.2012;18(6):903-912.
23. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL™* 4.0 as a
Pediatric Population Health Measure: Feasibility, Reliability, and
Validity. Ambulatory Pediatrics. 2003;3(6):329-341.
24. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of
the Pediatric Quality of Life Inventory version 4.0 generic core scales
in healthy and patient populations. Med Care. 2001;39(8):800-812.
25. Zheng DJ, Lu X, Schore RJ, et al. Longitudinal analysis of
quality‐of‐life outcomes in children during treatment for acute
lymphoblastic leukemia: A report from the Children’s Oncology Group
AALL0932 trial. Cancer. 2018;124(3):571-579.
26. Bureau UC. American Community Survey Data. 2022;
https://www.census.gov/programs-surveys/acs/data.html. Accessed
June 24, 2022, 2022.
27. Joshua TV, Rizzo JD, Zhang M-J, et al. Access to hematopoietic stem
cell transplantation. Cancer. 2010;116(14):3469-3476.
28. Paulson K, Brazauskas R, Khera N, et al. Inferior Access to
Allogeneic Transplant in Disadvantaged Populations: A Center for
International Blood and Marrow Transplant Research Analysis.Biology of Blood and Marrow Transplantation.2019;25(10):2086-2090.
29. Parker C, Berkovic D, Ayton D, Zomer E, Liew D, Wei A. Patient
Perceived Financial Burden in Haematological Malignancies: A Systematic
Review. Current Oncology. 2022;29(6):3807-3824.
30. Bona K, London WB, Guo D, Abel G, Lehmann L, Wolfe J. Prevalence and
Impact of Financial Hardship among New England Pediatric Stem Cell
Transplantation Families. Biology of Blood and Marrow
Transplantation. 2015;21(2):312-318.
31. Brown-Iannuzzi JL, Payne BK, Rini C, DuHamel KN, Redd WH. Objective
and subjective socioeconomic status and health symptoms in patients
following hematopoietic stem cell transplantation.Psycho-Oncology. 2014;23(7):740-748.
32. Rove KO, Edney JC, Brockel MA. Enhanced recovery after surgery in
children: Promising, evidence-based multidisciplinary care.Pediatric Anesthesia. 2018;28(6):482-492.
33. Ajarmeh S, Er L, Brin G, Djurdjev O, Dionne JM. The effect of a
multidisciplinary care clinic on the outcomes in pediatric chronic
kidney disease. Pediatric Nephrology. 2012;27(10):1921-1927.
34. Cantrell MA, Ruble K. Multidisciplinary care in pediatric oncology.Journal of Multidisciplinary Healthcare. 2011;4:171-181.
35. Hashmi S, Carpenter P, Khera N, Tichelli A, Savani BN. Lost in
Transition: The Essential Need for Long-Term Follow-Up Clinic for Blood
and Marrow Transplantation Survivors. Biology of Blood and Marrow
Transplantation. 2015;21(2):225-232.
36. Patzer RE, Paul S, Plantinga L, et al. A Randomized Trial to Reduce
Disparities in Referral for Transplant Evaluation. J Am Soc
Nephrol. 2017;28(3):935-942.
37. Beattie S, Lebel S, Tay J. The influence of social support on
hematopoietic stem cell transplantation survival: a systematic review of
literature. PLoS One. 2013;8(4):e61586.
38. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL™
in pediatric cancer. Cancer. 2002;94(7):2090-2106.
39. Ng VL, Alonso EM, Bucuvalas JC, et al. Health status of children
alive 10 years after pediatric liver transplantation performed in the US
and Canada: report of the studies of pediatric liver transplantation
experience. J Pediatr. 2012;160(5):820-826.e823.
40. Nuss SL, Wilson ME. Health-Related Quality of Life Following
Hematopoietic Stem Cell Transplant During Childhood. Journal of
Pediatric Oncology Nursing. 2007;24(2):106-115.
41. Bhatia M, Kolva E, Cimini L, et al. Health-Related Quality of Life
after Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell
Disease. Biology of Blood and Marrow Transplantation.2015;21(4):666-672.
42. Oberg JA, Bender JG, Morris E, et al. Pediatric allo-SCT for
malignant and non-malignant diseases: impact on health-related quality
of life outcomes. Bone Marrow Transplantation.2013;48(6):787-793.
43. Gandhi K, Lim E, Davis J, Chen JJ. Racial-ethnic disparities in
self-reported health status among US adults adjusted for
sociodemographics and multimorbidities, National Health and Nutrition
Examination Survey 2011-2014. Ethn Health. 2020;25(1):65-78.
44. Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The
PedsQL™ Family Impact Module: Preliminary reliability and validity.Health and Quality of Life Outcomes. 2004;2(1):55.
45. Ku E, McCulloch CE, Grimes BA, Johansen KL. Racial and Ethnic
Disparities in Survival of Children with ESRD. Journal of the
American Society of Nephrology. 2017;28(5):1584.
46. Majhail NS, Nayyar S, Santibañez ME, Murphy EA, Denzen EM. Racial
disparities in hematopoietic cell transplantation in the United States.Bone Marrow Transplant. 2012;47(11):1385-1390.
47. Malek SK, Keys BJ, Kumar S, Milford E, Tullius SG. Racial and ethnic
disparities in kidney transplantation. Transplant International.2011;24(5):419-424.
48. Warren C, Carpenter A-M, Neal D, Andreoni K, Sarosi G, Zarrinpar A.
Racial Disparity in Liver Transplantation Listing. Journal of the
American College of Surgeons. 2021;232(4):526-534.